(88 days)
The LifeScan SureStepPro blood glucose monitoring system is intended for quantitative measurement of glucose in a sample of whole blood. It can be used in a clinical setting to measure glucose in arterial, venous, and capillary samples in both adults and neonates. It can also be used by lay persons for capillary blood glucose monitoring in the home.
The SureStepPro blood glucose monitoring system consists of a qlucose reagent test strip, a reflectance photometer, and quality control solutions. A data management system for hospital tracking of patient and quality control information will also be available.
The provided text is a summary of a 510(k) submission for a blood glucose monitoring system from 1997. It describes the device, its intended use, and claims substantial equivalence to previously marketed devices. However, the document does not contain any information regarding specific acceptance criteria, performance studies, sample sizes for test or training sets, ground truth establishment, expert involvement, or adjudication methods.
The nature of a 510(k) summary from 1997 is generally to demonstrate substantial equivalence to a predicate device, and often the detailed performance data and study methodologies are contained in the full 510(k) submission, which is not provided here.
Therefore, I cannot fulfill your request for the specific details outlined in your prompt based solely on the provided input.
To answer your questions, I would need additional documentation, such as the full 510(k) submission for K970566, or a more contemporary regulatory filing that typically includes these detailed performance studies.
§ 862.1345 Glucose test system.
(a)
Identification. A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.(b)
Classification. Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.